Otsuka preparing the ground for largest ever pharma IPO
This article was originally published in Scrip
Otsuka Holdings has confirmed that it will list on the Tokyo Stock Exchange on 15 December in what is expected to be the largest ever float of a pharmaceuticals company.
You may also be interested in...
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.